Oxygen saturation targets in neonatal care: A narrative review

Optimal oxygenation requires the delivery of oxygen to meet tissue metabolic demands while minimizing hypoxic pulmonary vasoconstriction and oxygen toxicity. Oxygen saturation by pulse oximetry (SpO2) is a continuous, non-invasive method for monitoring oxygenation. The optimal SpO2 target varies dur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Early human development 2024-12, Vol.199, p.106134, Article 106134
Hauptverfasser: Nguyen, Tri C., Madappa, Rajeshwari, Siefkes, Heather M., Lim, Michelle J., Siddegowda, Kanya Mysore, Lakshminrusimha, Satyan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 106134
container_title Early human development
container_volume 199
creator Nguyen, Tri C.
Madappa, Rajeshwari
Siefkes, Heather M.
Lim, Michelle J.
Siddegowda, Kanya Mysore
Lakshminrusimha, Satyan
description Optimal oxygenation requires the delivery of oxygen to meet tissue metabolic demands while minimizing hypoxic pulmonary vasoconstriction and oxygen toxicity. Oxygen saturation by pulse oximetry (SpO2) is a continuous, non-invasive method for monitoring oxygenation. The optimal SpO2 target varies during pregnancy and neonatal period. Maternal SpO2 should ideally be ≥95 % to ensure adequate fetal oxygenation. Term neonates can be resuscitated with an initial oxygen concentration of 21 %, while moderately preterm infants require 21–30 %. Extremely preterm infants may need higher FiO2, followed by titration to desired SpO2 targets. During the NICU course, extremely preterm infants managed with an 85–89 % SpO2 target compared to 90–94 % are associated with a reduced incidence of severe retinopathy of prematurity (ROP) requiring treatment, but with higher mortality. During the later stages of ROP progression, studies suggest that higher SpO2 targets may help limit progression. A target SpO2 of 90–95 % is generally reasonable for term infants with respiratory disease or pulmonary hypertension, with few exceptions such as severe acidosis, therapeutic hypothermia, and possibly dark skin pigmentation, where 93–98 % may be preferred. Infants with cyanotic heart disease and single-ventricle physiology have lower SpO2 targets to avoid pulmonary over-circulation. In low- and middle-income countries (LMICs), the scarcity of oxygen blenders and continuous monitoring may pose a challenge, increasing the risks of both hypoxia and hyperoxia, which can lead to mortality and ROP, respectively. Strategies to mitigate hyperoxia among preterm infants in LMICs are urgently needed to reduce the incidence of ROP. •Oxygen therapy should balance tissue delivery preventing both hypoxia and toxicity.•Initial oxygen for resuscitation varies from 21 % in term to 21–30 % or higher in preterm.•Preductal SpO2 of 90–97 % results in low pulmonary vascular resistance.•Lack of oxygen blenders increases the risk of hyperoxia in resource-limited settings.•Maternal SpO2 ≥ 95 % ensures adequate oxygenation for the fetus.
doi_str_mv 10.1016/j.earlhumdev.2024.106134
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3123073547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378378224002032</els_id><sourcerecordid>3123073547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c249t-1eab582b7e6ef7bd51cd1b7c04294bcb285b36433c960c1ab3da1b568ebdba153</originalsourceid><addsrcrecordid>eNqFkMlKA0EQQBtRTIz-gvTRy8TeZvMgxOAGgVz03PRSiR1mid0z0fy9Hcbl6KEoKF5tDyFMyZQSml1vpqB89dbXFnZTRpiI5YxycYTGtMhZkjHOjtGY8LxIYrAROgthQwhJi5KcohEvRUFpysfodvm5X0ODg-p6rzrXNrhTfg1dwK7BDbSN6lSFjfJwg2e4Uf5A7QB72Dn4OEcnK1UFuPjOE_T6cP8yf0oWy8fn-WyRGCbKLqGgdFownUMGq1zblBpLdW6IYKXQRrMi1TwTnJsyI4Yqza2iOs0K0FareOgEXQ1zt7597yF0snbBQFWpeGIfJKeMk5ynIo9oMaDGtyF4WMmtd7Xye0mJPNiTG_lnTx7sycFebL383tLrGuxv44-uCNwNAMRf4_9eBuOgMWCdB9NJ27r_t3wBf3yGHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3123073547</pqid></control><display><type>article</type><title>Oxygen saturation targets in neonatal care: A narrative review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Nguyen, Tri C. ; Madappa, Rajeshwari ; Siefkes, Heather M. ; Lim, Michelle J. ; Siddegowda, Kanya Mysore ; Lakshminrusimha, Satyan</creator><creatorcontrib>Nguyen, Tri C. ; Madappa, Rajeshwari ; Siefkes, Heather M. ; Lim, Michelle J. ; Siddegowda, Kanya Mysore ; Lakshminrusimha, Satyan</creatorcontrib><description>Optimal oxygenation requires the delivery of oxygen to meet tissue metabolic demands while minimizing hypoxic pulmonary vasoconstriction and oxygen toxicity. Oxygen saturation by pulse oximetry (SpO2) is a continuous, non-invasive method for monitoring oxygenation. The optimal SpO2 target varies during pregnancy and neonatal period. Maternal SpO2 should ideally be ≥95 % to ensure adequate fetal oxygenation. Term neonates can be resuscitated with an initial oxygen concentration of 21 %, while moderately preterm infants require 21–30 %. Extremely preterm infants may need higher FiO2, followed by titration to desired SpO2 targets. During the NICU course, extremely preterm infants managed with an 85–89 % SpO2 target compared to 90–94 % are associated with a reduced incidence of severe retinopathy of prematurity (ROP) requiring treatment, but with higher mortality. During the later stages of ROP progression, studies suggest that higher SpO2 targets may help limit progression. A target SpO2 of 90–95 % is generally reasonable for term infants with respiratory disease or pulmonary hypertension, with few exceptions such as severe acidosis, therapeutic hypothermia, and possibly dark skin pigmentation, where 93–98 % may be preferred. Infants with cyanotic heart disease and single-ventricle physiology have lower SpO2 targets to avoid pulmonary over-circulation. In low- and middle-income countries (LMICs), the scarcity of oxygen blenders and continuous monitoring may pose a challenge, increasing the risks of both hypoxia and hyperoxia, which can lead to mortality and ROP, respectively. Strategies to mitigate hyperoxia among preterm infants in LMICs are urgently needed to reduce the incidence of ROP. •Oxygen therapy should balance tissue delivery preventing both hypoxia and toxicity.•Initial oxygen for resuscitation varies from 21 % in term to 21–30 % or higher in preterm.•Preductal SpO2 of 90–97 % results in low pulmonary vascular resistance.•Lack of oxygen blenders increases the risk of hyperoxia in resource-limited settings.•Maternal SpO2 ≥ 95 % ensures adequate oxygenation for the fetus.</description><identifier>ISSN: 0378-3782</identifier><identifier>ISSN: 1872-6232</identifier><identifier>EISSN: 1872-6232</identifier><identifier>DOI: 10.1016/j.earlhumdev.2024.106134</identifier><identifier>PMID: 39481153</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Free radicals ; Humans ; Hyperoxia ; Hypoxia ; Infant, Newborn ; Infant, Premature ; Oximetry - methods ; Oxygen ; Oxygen Saturation ; Pulmonary vascular resistance ; Retinopathy of Prematurity - prevention &amp; control ; Retinopathy of Prematurity - therapy</subject><ispartof>Early human development, 2024-12, Vol.199, p.106134, Article 106134</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c249t-1eab582b7e6ef7bd51cd1b7c04294bcb285b36433c960c1ab3da1b568ebdba153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.earlhumdev.2024.106134$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39481153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Tri C.</creatorcontrib><creatorcontrib>Madappa, Rajeshwari</creatorcontrib><creatorcontrib>Siefkes, Heather M.</creatorcontrib><creatorcontrib>Lim, Michelle J.</creatorcontrib><creatorcontrib>Siddegowda, Kanya Mysore</creatorcontrib><creatorcontrib>Lakshminrusimha, Satyan</creatorcontrib><title>Oxygen saturation targets in neonatal care: A narrative review</title><title>Early human development</title><addtitle>Early Hum Dev</addtitle><description>Optimal oxygenation requires the delivery of oxygen to meet tissue metabolic demands while minimizing hypoxic pulmonary vasoconstriction and oxygen toxicity. Oxygen saturation by pulse oximetry (SpO2) is a continuous, non-invasive method for monitoring oxygenation. The optimal SpO2 target varies during pregnancy and neonatal period. Maternal SpO2 should ideally be ≥95 % to ensure adequate fetal oxygenation. Term neonates can be resuscitated with an initial oxygen concentration of 21 %, while moderately preterm infants require 21–30 %. Extremely preterm infants may need higher FiO2, followed by titration to desired SpO2 targets. During the NICU course, extremely preterm infants managed with an 85–89 % SpO2 target compared to 90–94 % are associated with a reduced incidence of severe retinopathy of prematurity (ROP) requiring treatment, but with higher mortality. During the later stages of ROP progression, studies suggest that higher SpO2 targets may help limit progression. A target SpO2 of 90–95 % is generally reasonable for term infants with respiratory disease or pulmonary hypertension, with few exceptions such as severe acidosis, therapeutic hypothermia, and possibly dark skin pigmentation, where 93–98 % may be preferred. Infants with cyanotic heart disease and single-ventricle physiology have lower SpO2 targets to avoid pulmonary over-circulation. In low- and middle-income countries (LMICs), the scarcity of oxygen blenders and continuous monitoring may pose a challenge, increasing the risks of both hypoxia and hyperoxia, which can lead to mortality and ROP, respectively. Strategies to mitigate hyperoxia among preterm infants in LMICs are urgently needed to reduce the incidence of ROP. •Oxygen therapy should balance tissue delivery preventing both hypoxia and toxicity.•Initial oxygen for resuscitation varies from 21 % in term to 21–30 % or higher in preterm.•Preductal SpO2 of 90–97 % results in low pulmonary vascular resistance.•Lack of oxygen blenders increases the risk of hyperoxia in resource-limited settings.•Maternal SpO2 ≥ 95 % ensures adequate oxygenation for the fetus.</description><subject>Free radicals</subject><subject>Humans</subject><subject>Hyperoxia</subject><subject>Hypoxia</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Oximetry - methods</subject><subject>Oxygen</subject><subject>Oxygen Saturation</subject><subject>Pulmonary vascular resistance</subject><subject>Retinopathy of Prematurity - prevention &amp; control</subject><subject>Retinopathy of Prematurity - therapy</subject><issn>0378-3782</issn><issn>1872-6232</issn><issn>1872-6232</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlKA0EQQBtRTIz-gvTRy8TeZvMgxOAGgVz03PRSiR1mid0z0fy9Hcbl6KEoKF5tDyFMyZQSml1vpqB89dbXFnZTRpiI5YxycYTGtMhZkjHOjtGY8LxIYrAROgthQwhJi5KcohEvRUFpysfodvm5X0ODg-p6rzrXNrhTfg1dwK7BDbSN6lSFjfJwg2e4Uf5A7QB72Dn4OEcnK1UFuPjOE_T6cP8yf0oWy8fn-WyRGCbKLqGgdFownUMGq1zblBpLdW6IYKXQRrMi1TwTnJsyI4Yqza2iOs0K0FareOgEXQ1zt7597yF0snbBQFWpeGIfJKeMk5ynIo9oMaDGtyF4WMmtd7Xye0mJPNiTG_lnTx7sycFebL383tLrGuxv44-uCNwNAMRf4_9eBuOgMWCdB9NJ27r_t3wBf3yGHQ</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Nguyen, Tri C.</creator><creator>Madappa, Rajeshwari</creator><creator>Siefkes, Heather M.</creator><creator>Lim, Michelle J.</creator><creator>Siddegowda, Kanya Mysore</creator><creator>Lakshminrusimha, Satyan</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Oxygen saturation targets in neonatal care: A narrative review</title><author>Nguyen, Tri C. ; Madappa, Rajeshwari ; Siefkes, Heather M. ; Lim, Michelle J. ; Siddegowda, Kanya Mysore ; Lakshminrusimha, Satyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c249t-1eab582b7e6ef7bd51cd1b7c04294bcb285b36433c960c1ab3da1b568ebdba153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Free radicals</topic><topic>Humans</topic><topic>Hyperoxia</topic><topic>Hypoxia</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Oximetry - methods</topic><topic>Oxygen</topic><topic>Oxygen Saturation</topic><topic>Pulmonary vascular resistance</topic><topic>Retinopathy of Prematurity - prevention &amp; control</topic><topic>Retinopathy of Prematurity - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Tri C.</creatorcontrib><creatorcontrib>Madappa, Rajeshwari</creatorcontrib><creatorcontrib>Siefkes, Heather M.</creatorcontrib><creatorcontrib>Lim, Michelle J.</creatorcontrib><creatorcontrib>Siddegowda, Kanya Mysore</creatorcontrib><creatorcontrib>Lakshminrusimha, Satyan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Early human development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Tri C.</au><au>Madappa, Rajeshwari</au><au>Siefkes, Heather M.</au><au>Lim, Michelle J.</au><au>Siddegowda, Kanya Mysore</au><au>Lakshminrusimha, Satyan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxygen saturation targets in neonatal care: A narrative review</atitle><jtitle>Early human development</jtitle><addtitle>Early Hum Dev</addtitle><date>2024-12</date><risdate>2024</risdate><volume>199</volume><spage>106134</spage><pages>106134-</pages><artnum>106134</artnum><issn>0378-3782</issn><issn>1872-6232</issn><eissn>1872-6232</eissn><abstract>Optimal oxygenation requires the delivery of oxygen to meet tissue metabolic demands while minimizing hypoxic pulmonary vasoconstriction and oxygen toxicity. Oxygen saturation by pulse oximetry (SpO2) is a continuous, non-invasive method for monitoring oxygenation. The optimal SpO2 target varies during pregnancy and neonatal period. Maternal SpO2 should ideally be ≥95 % to ensure adequate fetal oxygenation. Term neonates can be resuscitated with an initial oxygen concentration of 21 %, while moderately preterm infants require 21–30 %. Extremely preterm infants may need higher FiO2, followed by titration to desired SpO2 targets. During the NICU course, extremely preterm infants managed with an 85–89 % SpO2 target compared to 90–94 % are associated with a reduced incidence of severe retinopathy of prematurity (ROP) requiring treatment, but with higher mortality. During the later stages of ROP progression, studies suggest that higher SpO2 targets may help limit progression. A target SpO2 of 90–95 % is generally reasonable for term infants with respiratory disease or pulmonary hypertension, with few exceptions such as severe acidosis, therapeutic hypothermia, and possibly dark skin pigmentation, where 93–98 % may be preferred. Infants with cyanotic heart disease and single-ventricle physiology have lower SpO2 targets to avoid pulmonary over-circulation. In low- and middle-income countries (LMICs), the scarcity of oxygen blenders and continuous monitoring may pose a challenge, increasing the risks of both hypoxia and hyperoxia, which can lead to mortality and ROP, respectively. Strategies to mitigate hyperoxia among preterm infants in LMICs are urgently needed to reduce the incidence of ROP. •Oxygen therapy should balance tissue delivery preventing both hypoxia and toxicity.•Initial oxygen for resuscitation varies from 21 % in term to 21–30 % or higher in preterm.•Preductal SpO2 of 90–97 % results in low pulmonary vascular resistance.•Lack of oxygen blenders increases the risk of hyperoxia in resource-limited settings.•Maternal SpO2 ≥ 95 % ensures adequate oxygenation for the fetus.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>39481153</pmid><doi>10.1016/j.earlhumdev.2024.106134</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-3782
ispartof Early human development, 2024-12, Vol.199, p.106134, Article 106134
issn 0378-3782
1872-6232
1872-6232
language eng
recordid cdi_proquest_miscellaneous_3123073547
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Free radicals
Humans
Hyperoxia
Hypoxia
Infant, Newborn
Infant, Premature
Oximetry - methods
Oxygen
Oxygen Saturation
Pulmonary vascular resistance
Retinopathy of Prematurity - prevention & control
Retinopathy of Prematurity - therapy
title Oxygen saturation targets in neonatal care: A narrative review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A05%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxygen%20saturation%20targets%20in%20neonatal%20care:%20A%20narrative%20review&rft.jtitle=Early%20human%20development&rft.au=Nguyen,%20Tri%20C.&rft.date=2024-12&rft.volume=199&rft.spage=106134&rft.pages=106134-&rft.artnum=106134&rft.issn=0378-3782&rft.eissn=1872-6232&rft_id=info:doi/10.1016/j.earlhumdev.2024.106134&rft_dat=%3Cproquest_cross%3E3123073547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3123073547&rft_id=info:pmid/39481153&rft_els_id=S0378378224002032&rfr_iscdi=true